Drug intelligence / Profile preview

autologous adipose-derived mesenchymal stem cells + fibrin glue

Development stage
Unknown
Lead developer
Kasiak Research
Modality
Cell Therapies
Administration
Intralesional, Implant
01

Overview

Autologous adipose-derived mesenchymal stem cells (AD-MSCs) combined with fibrin glue is a regenerative cell therapy approach. It involves the isolation of mesenchymal stem cells from a patient's own adipose tissue, which are then suspended in or applied with a fibrin glue matrix. The fibrin glue acts as a scaffold or carrier, facilitating the localization and retention of the cells at the site of injury while providing an extracellular matrix-like environment. This combination is primarily investigated for orthopedic and neurological repairs, such as rotator cuff tears, peripheral nerve regeneration, and spinal cord injuries. The therapeutic effect is mediated through the secretion of paracrine factors (neurotrophic and angiogenic growth factors), differentiation into relevant cell lineages, and structural support for tissue healing.

Other names
autologous AD-MSCs + fibrin glueadipose-derived stem cells with fibrin sealantAD-MSCs in fibrin matrix

Beyond the preview

Go deeper on autologous adipose-derived mesenchymal stem cells + fibrin glue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells + fibrin glue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call